The present invention relates to bilayer tablets comprising a metformin hydrochloride formulation as the first layer, an SGLT2 inhibitor formulation as the second layer, and optionally a film coating. The present invention further relates to medical uses of said bilayer tablets and to pharmaceutical combinations comprising said bilayer tablets.